Химическая структура
Биологическая активность
Vantictumab (OMP-18R5) is a fully human IgG2 моноклональный антитело. Vantictumab inhibits Wnt pathway signaling by связывание to FZD1/2/5/7/8 receptors. Vantictumab is being studied against cancers such as metastatic HER2-negative breast cancer and metastatic pancreatic adenocarcinoma.
Оригинал на английском
Vantictumab (OMP-18R5) is a fully human IgG2 monoclonal antibody. Vantictumab inhibits Wnt pathway signaling by binding to FZD1/2/5/7/8 receptors. Vantictumab is being studied against cancers such as metastatic HER2-negative breast cancer and metastatic pancreatic adenocarcinoma.
Химические свойства
- CAS №
- 1345009-45-1 pH value: Corresponds to reference standard: PASS Non-reduced CE-SDS: >95% SEC-HPLC: >95% Isoelectric Point: Corresponds to reference standard Osmolality: Corresponds to reference standard: PASS Peptide mapping: Corresponds to reference standard: PASS N-terminal sequence: Corresponds to reference standard: PASS
Безопасность и документация
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.
Сертификат анализа (COA)По запросу
Паспорт безопасности (SDS)По запросу
Спектральные данныеHPLC / NMR / MS
Сертификат происхожденияПри необходимости